Malicious masquerade: myxoid melanoma.
Hitchcock MG, White WL.
Semin Diagn Pathol. 1998 Aug;15(3):195-202.
Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM, Cardona K, Koseła-Paterczyk H, Rutkowski P.
Surg Oncol Clin N Am. 2022 Jul;31(3):419-430. doi: 10.1016/j.soc.2022.03.006.
Melanoma developing in a nevoid melanocytoma with myxoid changes: a case report.
Kao AS, St Claire K, Bedford LM, Mehregan DR, Andea AA, Kouba D.
Int J Clin Exp Pathol. 2022 Apr 15;15(4):201-205. eCollection 2022.
Tumors of the conjunctiva and cornea.
Shields CL, Shields JA.
Indian J Ophthalmol. 2019 Dec;67(12):1930-1948. doi: 10.4103/ijo.IJO_2040_19.
Fine needle aspiration of malignant melanoma with myxoid features: A case report with molecular analysis.
Felty CC, Jackson CR, Marotti JD, Liu X.
Diagn Cytopathol. 2020 Apr;48(4):390-395. doi: 10.1002/dc.24376. Epub 2019 Dec 24.
Primary myxoid melanoma with dermoscopic findings.
Uzuncakmak TK, Zindanci I, Zemheri EI, Karadag AS, Kuru BC, Akdeniz N.
Dermatol Pract Concept. 2017 Apr 30;7(2):59-61. doi: 10.5826/dpc.0702a13. eCollection 2017 Apr.
PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors.
Kaczorowski M, Chłopek M, Kruczak A, Ryś J, Lasota J, Miettinen M.
Am J Surg Pathol. 2022 Nov 1;46(11):1467-1476. doi: 10.1097/PAS.0000000000001944. Epub 2022 Aug 16.
Myxoid melanoma: immunohistochemical studies and a review of the literature.
Patel P, Levin K, Waltz K, Helm KF.
J Am Acad Dermatol. 2002 Feb;46(2):264-70. doi: 10.1067/mjd.2002.119650.
Myxoid metastatic melanoma.
Garcia-Caballero T, Fraga M, Antunez JR, Perez-Becerra E, Beiras A, Forteza J.
Histopathology. 1991 Apr;18(4):371-3. doi: 10.1111/j.1365-2559.1991.tb00863.x.
Metastatic melanoma and rare melanoma variants: a review.
Lowe L.
Pathology. 2023 Mar;55(2):236-244. doi: 10.1016/j.pathol.2022.11.006. Epub 2022 Dec 21.
